NRW.BANK investment · Biotech
Phagestack receives NRW.BANK investment for targeted phage development
The financing supports a company applying phage libraries and computational tools to bacterial strain discovery.
Searching for targeted responses to bacteria
Phagestack works with bacteriophage libraries, bioinformatics and machine learning to identify targeted solutions against bacterial strains. Phages are viruses that infect bacteria; matching them to specific strains can inform the development of more focused antibacterial approaches.
NRW.BANK has made an investment in the German company. The amount and a detailed spending plan were not disclosed, so the announcement establishes new backing without specifying a programme milestone or the size of the work ahead.
Funding history
NRW.BANK investment · This roundUndisclosed